170 related articles for article (PubMed ID: 23704240)
1. Recent advances in the treatment of non-Hodgkin's lymphomas.
Abramson JS; Zelenetz AD
J Natl Compr Canc Netw; 2013 May; 11(5 Suppl):671-5. PubMed ID: 23704240
[TBL] [Abstract][Full Text] [Related]
2. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
3. Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.
Zelenetz AD
J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):797-800. PubMed ID: 24853220
[TBL] [Abstract][Full Text] [Related]
4. NCCN preliminary non-Hodgkin's lymphoma practice guidelines.
Oncology (Williston Park); 1997 Nov; 11(11A):281-46. PubMed ID: 9430195
[No Abstract] [Full Text] [Related]
5. Four Lymphomas in 1 Patient: A Unique Case of Triple Composite Non-Hodgkin Lymphoma Followed by Classical Hodgkin Lymphoma.
Tennese A; Skrabek PJ; Nasr MR; Sekiguchi DR; Morales C; Brown TC; Weisenburger DD; Perry AM
Int J Surg Pathol; 2017 May; 25(3):276-280. PubMed ID: 27688525
[TBL] [Abstract][Full Text] [Related]
6. [Follicular (nodular) non Hodgkin's lymphoma of tonsil--case report].
Osuch-Wójcikiewicz E; Rzepakowska A; Bruzgielewicz A; Wieczorek J
Otolaryngol Pol; 2007; 61(2):203-6. PubMed ID: 17668812
[TBL] [Abstract][Full Text] [Related]
7. Management of histologically indolent non-Hodgkin's lymphomas.
Solal-Celigny P
Baillieres Clin Haematol; 1996 Dec; 9(4):669-87. PubMed ID: 9138612
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the management of non-Hodgkin's lymphomas.
Gaynor ER; Fisher RI
Dis Mon; 1989 Sep; 35(9):597-650. PubMed ID: 2676434
[TBL] [Abstract][Full Text] [Related]
9. Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).
Herold M; Schulze A; Niederwieser D; Franke A; Fricke HJ; Richter P; Freund M; Ismer B; Dachselt K; Boewer C; Schirmer V; Weniger J; Pasold R; Winkelmann C; Klinkenstein C; Schulze M; Arzberger H; Bremer K; Hahnfeld S; Schwarzer A; Müller C; Müller C;
J Cancer Res Clin Oncol; 2006 Feb; 132(2):105-12. PubMed ID: 16088404
[TBL] [Abstract][Full Text] [Related]
10. Scoring system for the prediction of successful peripheral blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice.
Vantelon JM; Koscielny S; Brault P; Bourhis JH; Ribrag V; Pico J; Fenaux P; Munck JN
Bone Marrow Transplant; 2000 Mar; 25(5):495-9. PubMed ID: 10713625
[TBL] [Abstract][Full Text] [Related]
11. Non-Hodgkin's lymphomas, version 2.2014.
Zelenetz AD; Gordon LI; Wierda WG; Abramson JS; Advani RH; Andreadis CB; Bartlett N; Bellam N; Byrd JC; Czuczman MS; Fayad LE; Fisher RI; Glenn MJ; Harris NL; Hoppe RT; Horwitz SM; Kelsey CR; Kim YH; Krivacic S; LaCasce AS; Nademanee A; Porcu P; Press O; Rabinovitch R; Reddy N; Reid E; Sokol L; Swinnen LJ; Tsien C; Vose JM; Yahalom J; Zafar N; Dwyer M; Sundar H
J Natl Compr Canc Netw; 2014 Jun; 12(6):916-46. PubMed ID: 24925202
[TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive.
Li L; Hamilton L; Montgomery J; Stewart M
J Laryngol Otol; 2020 May; 134(5):460-462. PubMed ID: 32308160
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C
J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
Marcus R; Hagenbeek A
Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
[TBL] [Abstract][Full Text] [Related]
15. Hybrid cytogenetics of chronic lymphocytic leukemia and follicular cell lymphoma in a case of non-Hodgkin's lymphoma.
Babu Rao V; Kerketta L; Madkaikar M; Farah J; Ghosh K
Acta Haematol; 2006; 116(2):150-2. PubMed ID: 16914914
[No Abstract] [Full Text] [Related]
16. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).
Ghielmini M; Vitolo U; Kimby E; Montoto S; Walewski J; Pfreundschuh M; Federico M; Hoskin P; McNamara C; Caligaris-Cappio F; Stilgenbauer S; Marcus R; Trneny M; Dreger P; Montserrat E; Dreyling M;
Ann Oncol; 2013 Mar; 24(3):561-76. PubMed ID: 23175624
[TBL] [Abstract][Full Text] [Related]
17. A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.
Feugier P
Future Oncol; 2015; 11(9):1327-42. PubMed ID: 25952779
[TBL] [Abstract][Full Text] [Related]
18. Management of non-Hodgkin's lymphomas.
Mounter PJ; Lennard AL
Postgrad Med J; 1999 Jan; 75(879):2-6. PubMed ID: 10396578
[TBL] [Abstract][Full Text] [Related]
19. Guidelines to modern treatment of non-Hodgkin's lymphomas.
Bonadonna G; Bajetta E
Acta Haematol; 1987; 78 Suppl 1():157-62. PubMed ID: 3124440
[TBL] [Abstract][Full Text] [Related]
20. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
